Guardant Health (GH) return on equity (ROE)

Return on equity · fiscal 2023
-302.1%

Guardant Health (GH) earned a return on equity of -302.1% in fiscal 2023 (the year ended December 31, 2023). That is 785.6 percentage points higher than the -1087.7% of fiscal 2022. Figures as of 17 Nov 2026, 21:27 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2023
-302.1%
Change on fiscal 2022
+785.6 pts
Highest on record
-9.5%fiscal 2019
Lowest on record
-1087.7%fiscal 2022
Fiscal years on record
82016–2023

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Guardant Health return on equity (ROE), in more detail

Across the 8 fiscal years on record (2016–2023), the highest was -9.5% in fiscal 2019 and the lowest -1087.7% in fiscal 2022. The fiscal 2023 figure is higher than in 14% of the 7 earlier fiscal years on record, whose median is -27.0%.

History · 8 fiscal years

Return on equity by fiscal year

Guardant Health return on equity (ROE), year by year

Guardant Health (GH) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
2023-302.1% 785.6 pts up
2022-1087.7% 1028.1 pts down
2021-59.7% 40.7 pts down
2020-19.0% 9.5 pts down
2019-9.5% 8.1 pts up
2018-17.6% 9.4 pts up
2017-27.0% 30.9 pts up
2016-57.9%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of Guardant Health and comparable companies
CompanyReturn on equityFiscal year
Viatris VTRS-23.9%2025
Tenet Healthcare THC33.3%2025
BioNTech BNTX-5.9%2025
Guardant Health GH-302.1%2023
Alnylam Pharmaceuticals ALNY39.8%2025
Zimmer Biomet Holdings ZBH5.6%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on GH

Guardant Health, figure by figure

Guardant Health (GH) overview: price, valuation and scorecardAll health care companies by market value

Guardant Health return on equity (ROE): questions and answers

What is Guardant Health's return on equity?

Guardant Health (GH) earned a return on equity of -302.1% in fiscal 2023 (the year ended December 31, 2023). That is 785.6 percentage points higher than the -1087.7% of fiscal 2022.

Is Guardant Health's return on equity high or low compared with its own history?

The fiscal 2023 figure is higher than in 14% of the 7 earlier fiscal years on record, whose median is -27.0%.

What are the highest and lowest return on equity figures on record for Guardant Health?

Across the 8 fiscal years on record (2016–2023), the highest was -9.5% in fiscal 2019 and the lowest -1087.7% in fiscal 2022.

How is Guardant Health's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Guardant Health (GH) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/GH/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.